Acadia Healthcare (NASDAQ:ACHC) Stock Rating Lowered by StockNews.com

Acadia Healthcare (NASDAQ:ACHC) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a report issued on Friday.

A number of other research firms have also recently issued reports on ACHC. Barclays cut their target price on shares of Acadia Healthcare from $100.00 to $91.00 and set an “overweight” rating for the company in a research note on Thursday. Mizuho lowered their target price on Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a research note on Friday. TD Cowen upped their price objective on Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Stephens raised Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price for the company in a report on Friday, January 5th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price target on the stock in a research report on Thursday, April 25th. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $89.50.

Acadia Healthcare Stock Down 0.9 %

Shares of NASDAQ ACHC traded down $0.61 during trading hours on Friday, hitting $66.12. The company had a trading volume of 1,181,258 shares, compared to its average volume of 604,466. The stock has a market capitalization of $6.11 billion, a P/E ratio of -472.29, a price-to-earnings-growth ratio of 2.15 and a beta of 1.31. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. The firm’s 50 day moving average is $77.13 and its 200-day moving average is $77.61. Acadia Healthcare has a 1-year low of $64.74 and a 1-year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. The company had revenue of $768.10 million during the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a positive return on equity of 11.56% and a negative net margin of 0.38%. The business’s revenue was up 9.1% on a year-over-year basis. During the same period last year, the firm posted $0.75 earnings per share. On average, analysts expect that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Insider Activity

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 2.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in ACHC. Raymond James & Associates increased its position in Acadia Healthcare by 0.6% during the 3rd quarter. Raymond James & Associates now owns 76,048 shares of the company’s stock valued at $5,347,000 after purchasing an additional 424 shares during the period. Bank of New York Mellon Corp grew its stake in Acadia Healthcare by 1.1% during the third quarter. Bank of New York Mellon Corp now owns 1,258,459 shares of the company’s stock worth $88,482,000 after purchasing an additional 13,765 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Acadia Healthcare by 20.1% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,920 shares of the company’s stock valued at $1,330,000 after acquiring an additional 3,167 shares in the last quarter. Mackenzie Financial Corp grew its holdings in Acadia Healthcare by 1.3% in the third quarter. Mackenzie Financial Corp now owns 15,737 shares of the company’s stock worth $1,063,000 after purchasing an additional 199 shares during the period. Finally, Strs Ohio increased its position in Acadia Healthcare by 14.2% in the 3rd quarter. Strs Ohio now owns 74,188 shares of the company’s stock valued at $5,216,000 after buying an additional 9,200 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.